Peripheral Vascular Stents (Cardiovascular) - Global Market Analysis and Forecast Model

Peripheral Vascular Stents (Cardiovascular) - Global Market Analysis and Forecast Model

Peripheral Vascular Stents (Cardiovascular) - Global Market Analysis and Forecast Model

Summary

Peripheral Vascular Stents (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Peripheral Vascular Stents market for the year 2020 and beyond. Peripheral vascular disease (also known as Peripheral artery disease - PAD) is a global public health and socioeconomic problem affecting millions of patients each year. The increasing prevalence of PAD worldwide can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use. The aging population, the high prevalence of the disease in the developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally-invasive techniques, such as angioplasty and stenting. Peripheral stenting involves inserting a stent into the blocked peripheral artery to widen it and allow for normal blood flow through the vessel.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Peripheral Vascular Stents market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Peripheral Vascular Stents market revenue by segment and market outlooks from 2015-2030.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Peripheral Vascular Stents market.
• Competitive dynamics insights and trends provided Peripheral Vascular Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - W. L. Gore & Associates Inc, Becton Dickinson and Co, Cook Group Inc, Boston Scientific Corp, Abbott Laboratories, Medtronic plc, Getinge AB, Cardinal Health Inc, Terumo Corp, Biotronik SE & Co KG, Kyoto Medical Planning Co Ltd, Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Peripheral Vascular Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Peripheral Vascular Stents market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Peripheral Vascular Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Vascular Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Peripheral Vascular Stents market from 2015-2030.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Please Note: this is delivered as an Excel.

Companies Mentioned

W. L. Gore & Associates Inc
Becton Dickinson and Co
Cook Group Inc
Boston Scientific Corp
Abbott Laboratories
Medtronic plc
Getinge AB
Cardinal Health Inc
Terumo Corp
Biotronik SE & Co KG
Kyoto Medical Planning Co Ltd
Others